Description
Vyndaqel (tafamidis) is a transthyretin stabilizer used for the treatment of transthyretin amyloid cardiomyopathy and polyneuropathy (TTR-FAP).
$14,981.67
TTR stabilizer for ATTR amyloidosis
Vyndaqel (tafamidis) is a transthyretin stabilizer used for the treatment of transthyretin amyloid cardiomyopathy and polyneuropathy (TTR-FAP).
Reviews
There are no reviews yet.